nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SIGMAR1—Tamoxifen—pancreatic cancer	0.095	0.123	CbGbCtD
Fluvoxamine—CYP1A1—Dacarbazine—pancreatic cancer	0.0424	0.0549	CbGbCtD
Fluvoxamine—CYP1A1—Tamoxifen—pancreatic cancer	0.0337	0.0437	CbGbCtD
Fluvoxamine—CYP2E1—Dacarbazine—pancreatic cancer	0.0327	0.0424	CbGbCtD
Fluvoxamine—CYP1A1—Erlotinib—pancreatic cancer	0.0287	0.0372	CbGbCtD
Fluvoxamine—CYP3A7—Tamoxifen—pancreatic cancer	0.027	0.035	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.027	0.035	CbGbCtD
Fluvoxamine—CYP2E1—Tamoxifen—pancreatic cancer	0.026	0.0338	CbGbCtD
Fluvoxamine—CYP2B6—Tamoxifen—pancreatic cancer	0.0257	0.0333	CbGbCtD
Fluvoxamine—CYP3A7—Irinotecan—pancreatic cancer	0.0207	0.0268	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0207	0.0268	CbGbCtD
Fluvoxamine—CYP3A5—Tamoxifen—pancreatic cancer	0.0202	0.0262	CbGbCtD
Fluvoxamine—CYP2B6—Irinotecan—pancreatic cancer	0.0197	0.0256	CbGbCtD
Fluvoxamine—CYP1A2—Dacarbazine—pancreatic cancer	0.0189	0.0245	CbGbCtD
Fluvoxamine—CYP3A5—Erlotinib—pancreatic cancer	0.0172	0.0223	CbGbCtD
Fluvoxamine—CYP2C19—Tamoxifen—pancreatic cancer	0.0163	0.0212	CbGbCtD
Fluvoxamine—CYP3A5—Irinotecan—pancreatic cancer	0.0155	0.0201	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—pancreatic cancer	0.0152	0.0197	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0152	0.0197	CbGbCtD
Fluvoxamine—CYP3A7—Sunitinib—pancreatic cancer	0.0151	0.0196	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0151	0.0196	CbGbCtD
Fluvoxamine—CYP1A2—Tamoxifen—pancreatic cancer	0.0151	0.0195	CbGbCtD
Fluvoxamine—CYP2C9—Tamoxifen—pancreatic cancer	0.0136	0.0176	CbGbCtD
Fluvoxamine—ABCB1—Tamoxifen—pancreatic cancer	0.0132	0.0171	CbGbCtD
Fluvoxamine—CYP1A2—Erlotinib—pancreatic cancer	0.0128	0.0166	CbGbCtD
Fluvoxamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0124	0.0161	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—pancreatic cancer	0.0114	0.0148	CbGbCtD
Fluvoxamine—ABCB1—Gemcitabine—pancreatic cancer	0.0113	0.0147	CbGbCtD
Fluvoxamine—CYP3A5—Sunitinib—pancreatic cancer	0.0113	0.0147	CbGbCtD
Fluvoxamine—ABCB1—Erlotinib—pancreatic cancer	0.0112	0.0145	CbGbCtD
Fluvoxamine—CYP1A2—Fluorouracil—pancreatic cancer	0.0111	0.0144	CbGbCtD
Fluvoxamine—CYP2B6—Doxorubicin—pancreatic cancer	0.0108	0.014	CbGbCtD
Fluvoxamine—CYP2D6—Erlotinib—pancreatic cancer	0.0106	0.0137	CbGbCtD
Fluvoxamine—ABCB1—Irinotecan—pancreatic cancer	0.0101	0.0131	CbGbCtD
Fluvoxamine—CYP2C9—Fluorouracil—pancreatic cancer	0.01	0.013	CbGbCtD
Fluvoxamine—CYP3A4—Tamoxifen—pancreatic cancer	0.00789	0.0102	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—pancreatic cancer	0.00741	0.00961	CbGbCtD
Fluvoxamine—ABCB1—Sunitinib—pancreatic cancer	0.00738	0.00956	CbGbCtD
Fluvoxamine—CYP3A4—Erlotinib—pancreatic cancer	0.00671	0.0087	CbGbCtD
Fluvoxamine—CYP3A4—Irinotecan—pancreatic cancer	0.00606	0.00785	CbGbCtD
Fluvoxamine—ABCB1—Doxorubicin—pancreatic cancer	0.00552	0.00716	CbGbCtD
Fluvoxamine—CYP2D6—Doxorubicin—pancreatic cancer	0.00521	0.00675	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—pancreatic cancer	0.00444	0.00576	CbGbCtD
Fluvoxamine—CYP3A4—Sunitinib—pancreatic cancer	0.00442	0.00573	CbGbCtD
Fluvoxamine—CYP3A4—Doxorubicin—pancreatic cancer	0.00331	0.00429	CbGbCtD
Fluvoxamine—Sweating—Epirubicin—pancreatic cancer	8.09e-05	0.000354	CcSEcCtD
Fluvoxamine—Pollakiuria—Doxorubicin—pancreatic cancer	8.09e-05	0.000354	CcSEcCtD
Fluvoxamine—Asthenia—Gemcitabine—pancreatic cancer	8.07e-05	0.000353	CcSEcCtD
Fluvoxamine—Haematuria—Epirubicin—pancreatic cancer	8.04e-05	0.000352	CcSEcCtD
Fluvoxamine—Confusional state—Docetaxel—pancreatic cancer	8.04e-05	0.000352	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	7.99e-05	0.00035	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.98e-05	0.000349	CcSEcCtD
Fluvoxamine—Oedema—Docetaxel—pancreatic cancer	7.98e-05	0.000349	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Docetaxel—pancreatic cancer	7.98e-05	0.000349	CcSEcCtD
Fluvoxamine—Weight increased—Doxorubicin—pancreatic cancer	7.97e-05	0.000349	CcSEcCtD
Fluvoxamine—Epistaxis—Epirubicin—pancreatic cancer	7.96e-05	0.000348	CcSEcCtD
Fluvoxamine—Pruritus—Gemcitabine—pancreatic cancer	7.95e-05	0.000348	CcSEcCtD
Fluvoxamine—Infection—Docetaxel—pancreatic cancer	7.93e-05	0.000347	CcSEcCtD
Fluvoxamine—Weight decreased—Doxorubicin—pancreatic cancer	7.92e-05	0.000347	CcSEcCtD
Fluvoxamine—Sinusitis—Epirubicin—pancreatic cancer	7.92e-05	0.000347	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.9e-05	0.000346	CcSEcCtD
Fluvoxamine—Diarrhoea—Irinotecan—pancreatic cancer	7.9e-05	0.000346	CcSEcCtD
Fluvoxamine—Agranulocytosis—Epirubicin—pancreatic cancer	7.87e-05	0.000345	CcSEcCtD
Fluvoxamine—Pneumonia—Doxorubicin—pancreatic cancer	7.85e-05	0.000344	CcSEcCtD
Fluvoxamine—Shock—Docetaxel—pancreatic cancer	7.85e-05	0.000344	CcSEcCtD
Fluvoxamine—Nervous system disorder—Docetaxel—pancreatic cancer	7.82e-05	0.000343	CcSEcCtD
Fluvoxamine—Pruritus—Fluorouracil—pancreatic cancer	7.82e-05	0.000342	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Docetaxel—pancreatic cancer	7.81e-05	0.000342	CcSEcCtD
Fluvoxamine—Drowsiness—Doxorubicin—pancreatic cancer	7.81e-05	0.000342	CcSEcCtD
Fluvoxamine—Tachycardia—Docetaxel—pancreatic cancer	7.79e-05	0.000341	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	7.74e-05	0.000339	CcSEcCtD
Fluvoxamine—Bradycardia—Epirubicin—pancreatic cancer	7.71e-05	0.000338	CcSEcCtD
Fluvoxamine—Diarrhoea—Gemcitabine—pancreatic cancer	7.69e-05	0.000337	CcSEcCtD
Fluvoxamine—Renal failure—Doxorubicin—pancreatic cancer	7.67e-05	0.000336	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.65e-05	0.000335	CcSEcCtD
Fluvoxamine—Dizziness—Irinotecan—pancreatic cancer	7.63e-05	0.000334	CcSEcCtD
Fluvoxamine—Haemoglobin—Epirubicin—pancreatic cancer	7.61e-05	0.000333	CcSEcCtD
Fluvoxamine—Stomatitis—Doxorubicin—pancreatic cancer	7.61e-05	0.000333	CcSEcCtD
Fluvoxamine—Jaundice—Doxorubicin—pancreatic cancer	7.61e-05	0.000333	CcSEcCtD
Fluvoxamine—Anorexia—Docetaxel—pancreatic cancer	7.6e-05	0.000333	CcSEcCtD
Fluvoxamine—Rhinitis—Epirubicin—pancreatic cancer	7.59e-05	0.000332	CcSEcCtD
Fluvoxamine—Conjunctivitis—Doxorubicin—pancreatic cancer	7.59e-05	0.000332	CcSEcCtD
Fluvoxamine—Urinary tract infection—Doxorubicin—pancreatic cancer	7.59e-05	0.000332	CcSEcCtD
Fluvoxamine—Hepatitis—Epirubicin—pancreatic cancer	7.57e-05	0.000332	CcSEcCtD
Fluvoxamine—Haemorrhage—Epirubicin—pancreatic cancer	7.57e-05	0.000332	CcSEcCtD
Fluvoxamine—Diarrhoea—Fluorouracil—pancreatic cancer	7.56e-05	0.000331	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Epirubicin—pancreatic cancer	7.54e-05	0.00033	CcSEcCtD
Fluvoxamine—Pharyngitis—Epirubicin—pancreatic cancer	7.52e-05	0.000329	CcSEcCtD
Fluvoxamine—Sweating—Doxorubicin—pancreatic cancer	7.48e-05	0.000328	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Epirubicin—pancreatic cancer	7.48e-05	0.000328	CcSEcCtD
Fluvoxamine—Oedema peripheral—Epirubicin—pancreatic cancer	7.46e-05	0.000327	CcSEcCtD
Fluvoxamine—Hypotension—Docetaxel—pancreatic cancer	7.45e-05	0.000326	CcSEcCtD
Fluvoxamine—Haematuria—Doxorubicin—pancreatic cancer	7.44e-05	0.000326	CcSEcCtD
Fluvoxamine—Urethral disorder—Epirubicin—pancreatic cancer	7.42e-05	0.000325	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.38e-05	0.000323	CcSEcCtD
Fluvoxamine—Epistaxis—Doxorubicin—pancreatic cancer	7.36e-05	0.000322	CcSEcCtD
Fluvoxamine—Vomiting—Irinotecan—pancreatic cancer	7.34e-05	0.000321	CcSEcCtD
Fluvoxamine—Sinusitis—Doxorubicin—pancreatic cancer	7.32e-05	0.000321	CcSEcCtD
Fluvoxamine—Dizziness—Fluorouracil—pancreatic cancer	7.31e-05	0.00032	CcSEcCtD
Fluvoxamine—Visual impairment—Epirubicin—pancreatic cancer	7.3e-05	0.00032	CcSEcCtD
Fluvoxamine—Agranulocytosis—Doxorubicin—pancreatic cancer	7.29e-05	0.000319	CcSEcCtD
Fluvoxamine—Rash—Irinotecan—pancreatic cancer	7.28e-05	0.000319	CcSEcCtD
Fluvoxamine—Dermatitis—Irinotecan—pancreatic cancer	7.27e-05	0.000318	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.27e-05	0.000318	CcSEcCtD
Fluvoxamine—Headache—Irinotecan—pancreatic cancer	7.23e-05	0.000317	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—pancreatic cancer	7.22e-05	0.000316	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—pancreatic cancer	7.16e-05	0.000314	CcSEcCtD
Fluvoxamine—Erythema multiforme—Epirubicin—pancreatic cancer	7.16e-05	0.000314	CcSEcCtD
Fluvoxamine—Vomiting—Gemcitabine—pancreatic cancer	7.15e-05	0.000313	CcSEcCtD
Fluvoxamine—Bradycardia—Doxorubicin—pancreatic cancer	7.13e-05	0.000312	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—pancreatic cancer	7.11e-05	0.000311	CcSEcCtD
Fluvoxamine—Somnolence—Docetaxel—pancreatic cancer	7.09e-05	0.000311	CcSEcCtD
Fluvoxamine—Rash—Gemcitabine—pancreatic cancer	7.09e-05	0.00031	CcSEcCtD
Fluvoxamine—Dermatitis—Gemcitabine—pancreatic cancer	7.08e-05	0.00031	CcSEcCtD
Fluvoxamine—Eye disorder—Epirubicin—pancreatic cancer	7.08e-05	0.00031	CcSEcCtD
Fluvoxamine—Tinnitus—Epirubicin—pancreatic cancer	7.06e-05	0.000309	CcSEcCtD
Fluvoxamine—Haemoglobin—Doxorubicin—pancreatic cancer	7.04e-05	0.000308	CcSEcCtD
Fluvoxamine—Headache—Gemcitabine—pancreatic cancer	7.04e-05	0.000308	CcSEcCtD
Fluvoxamine—Cardiac disorder—Epirubicin—pancreatic cancer	7.03e-05	0.000308	CcSEcCtD
Fluvoxamine—Vomiting—Fluorouracil—pancreatic cancer	7.03e-05	0.000308	CcSEcCtD
Fluvoxamine—Rhinitis—Doxorubicin—pancreatic cancer	7.03e-05	0.000308	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—pancreatic cancer	7.02e-05	0.000307	CcSEcCtD
Fluvoxamine—Haemorrhage—Doxorubicin—pancreatic cancer	7.01e-05	0.000307	CcSEcCtD
Fluvoxamine—Hepatitis—Doxorubicin—pancreatic cancer	7.01e-05	0.000307	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.97e-05	0.000305	CcSEcCtD
Fluvoxamine—Rash—Fluorouracil—pancreatic cancer	6.97e-05	0.000305	CcSEcCtD
Fluvoxamine—Dermatitis—Fluorouracil—pancreatic cancer	6.96e-05	0.000305	CcSEcCtD
Fluvoxamine—Pharyngitis—Doxorubicin—pancreatic cancer	6.96e-05	0.000305	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—pancreatic cancer	6.94e-05	0.000304	CcSEcCtD
Fluvoxamine—Headache—Fluorouracil—pancreatic cancer	6.92e-05	0.000303	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.92e-05	0.000303	CcSEcCtD
Fluvoxamine—Oedema peripheral—Doxorubicin—pancreatic cancer	6.9e-05	0.000302	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.89e-05	0.000302	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—pancreatic cancer	6.88e-05	0.000301	CcSEcCtD
Fluvoxamine—Angiopathy—Epirubicin—pancreatic cancer	6.87e-05	0.000301	CcSEcCtD
Fluvoxamine—Urethral disorder—Doxorubicin—pancreatic cancer	6.87e-05	0.000301	CcSEcCtD
Fluvoxamine—Nausea—Irinotecan—pancreatic cancer	6.86e-05	0.0003	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—pancreatic cancer	6.82e-05	0.000299	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—pancreatic cancer	6.82e-05	0.000299	CcSEcCtD
Fluvoxamine—Chills—Epirubicin—pancreatic cancer	6.8e-05	0.000298	CcSEcCtD
Fluvoxamine—Arrhythmia—Epirubicin—pancreatic cancer	6.77e-05	0.000296	CcSEcCtD
Fluvoxamine—Visual impairment—Doxorubicin—pancreatic cancer	6.75e-05	0.000296	CcSEcCtD
Fluvoxamine—Alopecia—Epirubicin—pancreatic cancer	6.69e-05	0.000293	CcSEcCtD
Fluvoxamine—Nausea—Gemcitabine—pancreatic cancer	6.68e-05	0.000292	CcSEcCtD
Fluvoxamine—Mental disorder—Epirubicin—pancreatic cancer	6.64e-05	0.000291	CcSEcCtD
Fluvoxamine—Erythema multiforme—Doxorubicin—pancreatic cancer	6.63e-05	0.00029	CcSEcCtD
Fluvoxamine—Malnutrition—Epirubicin—pancreatic cancer	6.59e-05	0.000289	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—pancreatic cancer	6.57e-05	0.000288	CcSEcCtD
Fluvoxamine—Nausea—Fluorouracil—pancreatic cancer	6.57e-05	0.000287	CcSEcCtD
Fluvoxamine—Eye disorder—Doxorubicin—pancreatic cancer	6.55e-05	0.000287	CcSEcCtD
Fluvoxamine—Tinnitus—Doxorubicin—pancreatic cancer	6.53e-05	0.000286	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.52e-05	0.000286	CcSEcCtD
Fluvoxamine—Cardiac disorder—Doxorubicin—pancreatic cancer	6.5e-05	0.000285	CcSEcCtD
Fluvoxamine—Flatulence—Epirubicin—pancreatic cancer	6.5e-05	0.000284	CcSEcCtD
Fluvoxamine—Tension—Epirubicin—pancreatic cancer	6.47e-05	0.000283	CcSEcCtD
Fluvoxamine—Dysgeusia—Epirubicin—pancreatic cancer	6.46e-05	0.000283	CcSEcCtD
Fluvoxamine—Nervousness—Epirubicin—pancreatic cancer	6.4e-05	0.00028	CcSEcCtD
Fluvoxamine—Back pain—Epirubicin—pancreatic cancer	6.38e-05	0.000279	CcSEcCtD
Fluvoxamine—Angiopathy—Doxorubicin—pancreatic cancer	6.36e-05	0.000278	CcSEcCtD
Fluvoxamine—Muscle spasms—Epirubicin—pancreatic cancer	6.34e-05	0.000278	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—pancreatic cancer	6.31e-05	0.000276	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—pancreatic cancer	6.31e-05	0.000276	CcSEcCtD
Fluvoxamine—Chills—Doxorubicin—pancreatic cancer	6.29e-05	0.000275	CcSEcCtD
Fluvoxamine—Arrhythmia—Doxorubicin—pancreatic cancer	6.26e-05	0.000274	CcSEcCtD
Fluvoxamine—Vision blurred—Epirubicin—pancreatic cancer	6.21e-05	0.000272	CcSEcCtD
Fluvoxamine—Alopecia—Doxorubicin—pancreatic cancer	6.19e-05	0.000271	CcSEcCtD
Fluvoxamine—Mental disorder—Doxorubicin—pancreatic cancer	6.14e-05	0.000269	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Epirubicin—pancreatic cancer	6.12e-05	0.000268	CcSEcCtD
Fluvoxamine—Malnutrition—Doxorubicin—pancreatic cancer	6.1e-05	0.000267	CcSEcCtD
Fluvoxamine—Anaemia—Epirubicin—pancreatic cancer	6.09e-05	0.000267	CcSEcCtD
Fluvoxamine—Agitation—Epirubicin—pancreatic cancer	6.06e-05	0.000265	CcSEcCtD
Fluvoxamine—Flatulence—Doxorubicin—pancreatic cancer	6.01e-05	0.000263	CcSEcCtD
Fluvoxamine—Tension—Doxorubicin—pancreatic cancer	5.99e-05	0.000262	CcSEcCtD
Fluvoxamine—Dysgeusia—Doxorubicin—pancreatic cancer	5.97e-05	0.000262	CcSEcCtD
Fluvoxamine—Malaise—Epirubicin—pancreatic cancer	5.95e-05	0.00026	CcSEcCtD
Fluvoxamine—Nervousness—Doxorubicin—pancreatic cancer	5.93e-05	0.000259	CcSEcCtD
Fluvoxamine—Vertigo—Epirubicin—pancreatic cancer	5.92e-05	0.000259	CcSEcCtD
Fluvoxamine—Syncope—Epirubicin—pancreatic cancer	5.91e-05	0.000259	CcSEcCtD
Fluvoxamine—Leukopenia—Epirubicin—pancreatic cancer	5.9e-05	0.000258	CcSEcCtD
Fluvoxamine—Back pain—Doxorubicin—pancreatic cancer	5.9e-05	0.000258	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—pancreatic cancer	5.88e-05	0.000257	CcSEcCtD
Fluvoxamine—Muscle spasms—Doxorubicin—pancreatic cancer	5.87e-05	0.000257	CcSEcCtD
Fluvoxamine—Palpitations—Epirubicin—pancreatic cancer	5.83e-05	0.000255	CcSEcCtD
Fluvoxamine—Loss of consciousness—Epirubicin—pancreatic cancer	5.79e-05	0.000254	CcSEcCtD
Fluvoxamine—Cough—Epirubicin—pancreatic cancer	5.75e-05	0.000252	CcSEcCtD
Fluvoxamine—Vision blurred—Doxorubicin—pancreatic cancer	5.75e-05	0.000252	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—pancreatic cancer	5.72e-05	0.000251	CcSEcCtD
Fluvoxamine—Convulsion—Epirubicin—pancreatic cancer	5.71e-05	0.00025	CcSEcCtD
Fluvoxamine—Hypertension—Epirubicin—pancreatic cancer	5.69e-05	0.000249	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.66e-05	0.000248	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—pancreatic cancer	5.64e-05	0.000247	CcSEcCtD
Fluvoxamine—Anaemia—Doxorubicin—pancreatic cancer	5.64e-05	0.000247	CcSEcCtD
Fluvoxamine—Myalgia—Epirubicin—pancreatic cancer	5.61e-05	0.000246	CcSEcCtD
Fluvoxamine—Chest pain—Epirubicin—pancreatic cancer	5.61e-05	0.000246	CcSEcCtD
Fluvoxamine—Arthralgia—Epirubicin—pancreatic cancer	5.61e-05	0.000246	CcSEcCtD
Fluvoxamine—Agitation—Doxorubicin—pancreatic cancer	5.61e-05	0.000245	CcSEcCtD
Fluvoxamine—Anxiety—Epirubicin—pancreatic cancer	5.59e-05	0.000245	CcSEcCtD
Fluvoxamine—Discomfort—Epirubicin—pancreatic cancer	5.55e-05	0.000243	CcSEcCtD
Fluvoxamine—Malaise—Doxorubicin—pancreatic cancer	5.5e-05	0.000241	CcSEcCtD
Fluvoxamine—Dry mouth—Epirubicin—pancreatic cancer	5.49e-05	0.00024	CcSEcCtD
Fluvoxamine—Vertigo—Doxorubicin—pancreatic cancer	5.48e-05	0.00024	CcSEcCtD
Fluvoxamine—Syncope—Doxorubicin—pancreatic cancer	5.47e-05	0.00024	CcSEcCtD
Fluvoxamine—Leukopenia—Doxorubicin—pancreatic cancer	5.46e-05	0.000239	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—pancreatic cancer	5.46e-05	0.000239	CcSEcCtD
Fluvoxamine—Confusional state—Epirubicin—pancreatic cancer	5.43e-05	0.000238	CcSEcCtD
Fluvoxamine—Palpitations—Doxorubicin—pancreatic cancer	5.39e-05	0.000236	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.38e-05	0.000236	CcSEcCtD
Fluvoxamine—Oedema—Epirubicin—pancreatic cancer	5.38e-05	0.000236	CcSEcCtD
Fluvoxamine—Loss of consciousness—Doxorubicin—pancreatic cancer	5.36e-05	0.000235	CcSEcCtD
Fluvoxamine—Infection—Epirubicin—pancreatic cancer	5.35e-05	0.000234	CcSEcCtD
Fluvoxamine—Cough—Doxorubicin—pancreatic cancer	5.32e-05	0.000233	CcSEcCtD
Fluvoxamine—Shock—Epirubicin—pancreatic cancer	5.29e-05	0.000232	CcSEcCtD
Fluvoxamine—Convulsion—Doxorubicin—pancreatic cancer	5.29e-05	0.000231	CcSEcCtD
Fluvoxamine—Nervous system disorder—Epirubicin—pancreatic cancer	5.28e-05	0.000231	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—pancreatic cancer	5.28e-05	0.000231	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.27e-05	0.000231	CcSEcCtD
Fluvoxamine—Hypertension—Doxorubicin—pancreatic cancer	5.27e-05	0.000231	CcSEcCtD
Fluvoxamine—Tachycardia—Epirubicin—pancreatic cancer	5.25e-05	0.00023	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Epirubicin—pancreatic cancer	5.2e-05	0.000228	CcSEcCtD
Fluvoxamine—Chest pain—Doxorubicin—pancreatic cancer	5.19e-05	0.000227	CcSEcCtD
Fluvoxamine—Arthralgia—Doxorubicin—pancreatic cancer	5.19e-05	0.000227	CcSEcCtD
Fluvoxamine—Myalgia—Doxorubicin—pancreatic cancer	5.19e-05	0.000227	CcSEcCtD
Fluvoxamine—Anxiety—Doxorubicin—pancreatic cancer	5.18e-05	0.000227	CcSEcCtD
Fluvoxamine—Discomfort—Doxorubicin—pancreatic cancer	5.13e-05	0.000225	CcSEcCtD
Fluvoxamine—Anorexia—Epirubicin—pancreatic cancer	5.13e-05	0.000225	CcSEcCtD
Fluvoxamine—Dry mouth—Doxorubicin—pancreatic cancer	5.08e-05	0.000222	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—pancreatic cancer	5.07e-05	0.000222	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—pancreatic cancer	5.03e-05	0.00022	CcSEcCtD
Fluvoxamine—Hypotension—Epirubicin—pancreatic cancer	5.03e-05	0.00022	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—pancreatic cancer	5.03e-05	0.00022	CcSEcCtD
Fluvoxamine—Confusional state—Doxorubicin—pancreatic cancer	5.02e-05	0.00022	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—pancreatic cancer	5e-05	0.000219	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.98e-05	0.000218	CcSEcCtD
Fluvoxamine—Oedema—Doxorubicin—pancreatic cancer	4.98e-05	0.000218	CcSEcCtD
Fluvoxamine—Infection—Doxorubicin—pancreatic cancer	4.95e-05	0.000217	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.9e-05	0.000215	CcSEcCtD
Fluvoxamine—Shock—Doxorubicin—pancreatic cancer	4.9e-05	0.000214	CcSEcCtD
Fluvoxamine—Nervous system disorder—Doxorubicin—pancreatic cancer	4.88e-05	0.000214	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.87e-05	0.000213	CcSEcCtD
Fluvoxamine—Insomnia—Epirubicin—pancreatic cancer	4.87e-05	0.000213	CcSEcCtD
Fluvoxamine—Tachycardia—Doxorubicin—pancreatic cancer	4.86e-05	0.000213	CcSEcCtD
Fluvoxamine—Paraesthesia—Epirubicin—pancreatic cancer	4.83e-05	0.000212	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.81e-05	0.000211	CcSEcCtD
Fluvoxamine—Dyspnoea—Epirubicin—pancreatic cancer	4.8e-05	0.00021	CcSEcCtD
Fluvoxamine—Somnolence—Epirubicin—pancreatic cancer	4.78e-05	0.000209	CcSEcCtD
Fluvoxamine—Anorexia—Doxorubicin—pancreatic cancer	4.75e-05	0.000208	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—pancreatic cancer	4.74e-05	0.000207	CcSEcCtD
Fluvoxamine—Dyspepsia—Epirubicin—pancreatic cancer	4.74e-05	0.000207	CcSEcCtD
Fluvoxamine—Decreased appetite—Epirubicin—pancreatic cancer	4.68e-05	0.000205	CcSEcCtD
Fluvoxamine—Hypotension—Doxorubicin—pancreatic cancer	4.65e-05	0.000204	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.65e-05	0.000203	CcSEcCtD
Fluvoxamine—Fatigue—Epirubicin—pancreatic cancer	4.64e-05	0.000203	CcSEcCtD
Fluvoxamine—Constipation—Epirubicin—pancreatic cancer	4.6e-05	0.000201	CcSEcCtD
Fluvoxamine—Pain—Epirubicin—pancreatic cancer	4.6e-05	0.000201	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.54e-05	0.000199	CcSEcCtD
Fluvoxamine—Insomnia—Doxorubicin—pancreatic cancer	4.5e-05	0.000197	CcSEcCtD
Fluvoxamine—Paraesthesia—Doxorubicin—pancreatic cancer	4.47e-05	0.000196	CcSEcCtD
Fluvoxamine—Dyspnoea—Doxorubicin—pancreatic cancer	4.44e-05	0.000194	CcSEcCtD
Fluvoxamine—Feeling abnormal—Epirubicin—pancreatic cancer	4.43e-05	0.000194	CcSEcCtD
Fluvoxamine—Somnolence—Doxorubicin—pancreatic cancer	4.43e-05	0.000194	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.4e-05	0.000193	CcSEcCtD
Fluvoxamine—Dyspepsia—Doxorubicin—pancreatic cancer	4.38e-05	0.000192	CcSEcCtD
Fluvoxamine—Decreased appetite—Doxorubicin—pancreatic cancer	4.33e-05	0.00019	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.3e-05	0.000188	CcSEcCtD
Fluvoxamine—Fatigue—Doxorubicin—pancreatic cancer	4.29e-05	0.000188	CcSEcCtD
Fluvoxamine—Urticaria—Epirubicin—pancreatic cancer	4.27e-05	0.000187	CcSEcCtD
Fluvoxamine—Pain—Doxorubicin—pancreatic cancer	4.26e-05	0.000186	CcSEcCtD
Fluvoxamine—Constipation—Doxorubicin—pancreatic cancer	4.26e-05	0.000186	CcSEcCtD
Fluvoxamine—Abdominal pain—Epirubicin—pancreatic cancer	4.25e-05	0.000186	CcSEcCtD
Fluvoxamine—Body temperature increased—Epirubicin—pancreatic cancer	4.25e-05	0.000186	CcSEcCtD
Fluvoxamine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.1e-05	0.00018	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.07e-05	0.000178	CcSEcCtD
Fluvoxamine—Hypersensitivity—Epirubicin—pancreatic cancer	3.96e-05	0.000174	CcSEcCtD
Fluvoxamine—Urticaria—Doxorubicin—pancreatic cancer	3.96e-05	0.000173	CcSEcCtD
Fluvoxamine—Abdominal pain—Doxorubicin—pancreatic cancer	3.94e-05	0.000172	CcSEcCtD
Fluvoxamine—Body temperature increased—Doxorubicin—pancreatic cancer	3.94e-05	0.000172	CcSEcCtD
Fluvoxamine—Asthenia—Epirubicin—pancreatic cancer	3.86e-05	0.000169	CcSEcCtD
Fluvoxamine—Pruritus—Epirubicin—pancreatic cancer	3.81e-05	0.000167	CcSEcCtD
Fluvoxamine—Diarrhoea—Epirubicin—pancreatic cancer	3.68e-05	0.000161	CcSEcCtD
Fluvoxamine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.67e-05	0.000161	CcSEcCtD
Fluvoxamine—Asthenia—Doxorubicin—pancreatic cancer	3.57e-05	0.000156	CcSEcCtD
Fluvoxamine—Dizziness—Epirubicin—pancreatic cancer	3.56e-05	0.000156	CcSEcCtD
Fluvoxamine—Pruritus—Doxorubicin—pancreatic cancer	3.52e-05	0.000154	CcSEcCtD
Fluvoxamine—Vomiting—Epirubicin—pancreatic cancer	3.42e-05	0.00015	CcSEcCtD
Fluvoxamine—Diarrhoea—Doxorubicin—pancreatic cancer	3.41e-05	0.000149	CcSEcCtD
Fluvoxamine—Rash—Epirubicin—pancreatic cancer	3.39e-05	0.000149	CcSEcCtD
Fluvoxamine—Dermatitis—Epirubicin—pancreatic cancer	3.39e-05	0.000148	CcSEcCtD
Fluvoxamine—Headache—Epirubicin—pancreatic cancer	3.37e-05	0.000148	CcSEcCtD
Fluvoxamine—Dizziness—Doxorubicin—pancreatic cancer	3.29e-05	0.000144	CcSEcCtD
Fluvoxamine—Nausea—Epirubicin—pancreatic cancer	3.2e-05	0.00014	CcSEcCtD
Fluvoxamine—Vomiting—Doxorubicin—pancreatic cancer	3.17e-05	0.000139	CcSEcCtD
Fluvoxamine—Rash—Doxorubicin—pancreatic cancer	3.14e-05	0.000137	CcSEcCtD
Fluvoxamine—Dermatitis—Doxorubicin—pancreatic cancer	3.14e-05	0.000137	CcSEcCtD
Fluvoxamine—Headache—Doxorubicin—pancreatic cancer	3.12e-05	0.000137	CcSEcCtD
Fluvoxamine—Nausea—Doxorubicin—pancreatic cancer	2.96e-05	0.000129	CcSEcCtD
